2024-05-09T15:20:36-05:00 2023-06-30 593070669 MSL PA 255 S ORANGE AVENUE SUITE 600 ORLANDO FL 32801 990 2022-07-01 010554709 FLORIDA PROTON THERAPY INSTITUTE INC FLOR 9045881800 2015 NORTH JEFFERSON STREET JACKSONVILLE FL 32206 KRISTIN HEATH EXECUTIVE DIRECTOR 9045881800 2024-05-09 1 KRISTIN HEATH 999009999 1 HARRY E HARP CPA P00176471 4077405400 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z KRISTIN HEATH 2015 NORTH JEFFERSON STREET JACKSONVILLE FL 32206 54480725 0 X WWW.FLORIDAPROTON.ORG X 2001 FL TO PROVIDE CANCER TREATMENT SERVICES, EDUCATIONAL PROGRAMS, AND TRAINING OPPORTUNITIES. 10 9 157 10 0 0 2103823 1862803 41702517 42323261 87533 485607 851777 883561 44745650 45555232 5425 8672 0 0 12100934 13011482 0 0 0 30937196 32108101 43043555 45128255 1702095 426977 138319097 137388571 54813588 52424249 83505509 84964322 X THE ORGANIZATION PROVIDES CANCER TREATMENT SERVICES, EDUCATIONAL PROGRAMS, AND TRAINING OPPORTUNITIES TO PROMOTE BASIC AND CLINICAL RESEARCH RELATED TO CANCER TREATMENTS AND TREATMENT PROGRAMS. 0 0 42756526 8672 43206822 THE PRIMARY ACTIVITY OF THE INSTITUTE IS TO PROVIDE PROTON AND CONVENTIONAL RADIATION THERAPY CANCER TREATMENT IN FACILITIES LOCATED IN JACKSONVILLE, FLORIDA.SEE SCHEDULE O FOR ADDITIONAL INFORMATION. SINCE COMMENCING CLINICAL OPERATIONS IN AUGUST OF 2006, THE INSTITUTE HAS CONTINUED TO FOCUS ITS RESOURCES ON FULFILLING ITS TRIPARTITE MISSION OF CLINICAL SERVICE, RESEARCH AND EDUCATION. TO DATE, THE INSTITUTE HAS PROVIDED CANCER TREATMENT SERVICES TO OVER 16,300 PATIENTS. THE CLINICAL PROGRAMS FOCUS ON MULTIPLE DISEASE SITES INCLUDING, BUT NOT LIMITED TO: CANCERS OF THE BRAIN AND CENTRAL NERVOUS SYSTEM, PROSTATE, SOFT TISSUES, EYE, BREAST, LUNG AND PANCREAS. THE INSTITUTE CURRENTLY OPERATES THE WORLD'S LARGEST PEDIATRIC PROGRAM UTILIZING PROTON THERAPY. SUPPLEMENTAL RESOURCES DEDICATED TO THE PEDIATRIC POPULATION INCLUDE: A FULL-TIME PLAY THERAPIST, A PEDIATRIC SOCIAL WORKER AND ART THERAPY STAFF. ALSO, PEDIATRIC PATIENTS ARE PROVIDED VARIOUS EDUCATIONAL AND "FUN" EVENTS SUPPORTED BY: THE LOCAL ZOO, SCIENCE LADY, FIRE DEPARTMENT, ETC.A CORNERSTONE OF THE INSTITUTE'S MISSION INCLUDES CLINICAL RESEARCH. CURRENTLY, THE INSTITUTE HAS A TOTAL OF 77 CLINICAL TRIAL STUDIES THAT HAVE BEEN COMPLETED OR ARE CURRENTLY OPEN FOR PATIENT ACCRUAL. APPROXIMATELY 97% OF THE INSTITUTE'S PATIENTS PARTICIPATE IN ONE OF THE CLINICAL TRIAL PROGRAMS OR OUTCOME STUDIES. LIKEWISE, THE INSTITUTE HAS DEVELOPED MULTIPLE EDUCATIONAL OPPORTUNITIES INCLUDING POST GRADUATE FELLOWSHIP TRAINING PROGRAMS IN PROTON RADIATION, PEDIATRICS AND IN MEDICAL PHYSICS. ALSO, THE INSTITUTE PROVIDES ONSITE TRAINING FOR SEVERAL RADIATION THERAPIST TRAINING PROGRAMS AND CHILD LIFE SPECIALIST SOCIAL WORKER PROGRAMS.AS A CANCER CENTER OF EXCELLENCE AND ACCREDITED RADIATION ONCOLOGY CENTER THROUGH THE AMERICAN COLLEGE OF RADIOLOGY (ACR), THE INSTITUTE CONTINUED TO PROVIDE OPTIMAL PATIENT CARE AND SERVICES. ALSO, THE INSTITUTE CONTINUES TO IMPROVE ITS ART-IN-MEDICINE PROGRAM, YOGA CLASSES, EDUCATIONAL ACTIVITIES, AND SURVIVORSHIP PROGRAM. THESE PROGRAMS ARE AIMED TO INCREASE THE HEALING ENVIRONMENT AND CULTURE CREATED AT THE INSTITUTE. PRIMARILY, THESE PROGRAMS ENHANCE WELLNESS, RELAXATION, PAIN MANAGEMENT, AND DECREASE ANXIETY AND STRESS IN PATIENTS AND CAREGIVERS UNDERGOING CANCER CARE AT THE INSTITUTE. THE PROGRAM HAS BEEN SO SUCCESSFUL THAT 99% OF PATIENTS WOULD DEFINITELY RECOMMEND THE INSTITUTE'S TREATMENT AND SERVICES.THE INSTITUTE IS RECOGNIZED AS THE WORLD LEADER IN PEDIATRIC PROTON RADIATION THERAPY AND CONTINUALLY PROVIDES TREATMENT TO PATIENTS FROM MANY COUNTRIES AROUND THE WORLD AS WELL AS MANY STATES WITHIN THE USA. THE ADULT PROGRAMS ARE EQUALLY RECOGNIZED FOR THE TREATMENT OPTIONS AND CONTINUED CANCER RESEARCH. CURRENTLY, THE INSTITUTE IS COLLECTING DATA ON RESEARCH STUDIES, EITHER FOR ITS OWN MISSION OR PARTICIPATING WITH OTHER NOTED MEDICAL INSTITUTIONS, SUCH AS ST. JUDE'S CHILDREN'S HOSPITAL, MASSACHUSETTS GENERAL HOSPITAL, ETC. IN FISCAL YEAR 2023 (JULY 1, 2022 THRU JUNE 30, 2023), THE INSTITUTE'S PROFESSIONAL STAFF PUBLISHED 15 STUDIES IN MAJOR MEDICAL PUBLICATIONS. 42756526 1 1 0 0 0 0 0 0 0 1 1 1 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 29 0 1 157 1 0 0 0 0 0 0 0 0 0 0 0 0 X 10 9 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 X WALTER MOORE 9045881553 2015 NORTH JEFFERSON STREET JACKSONVILLE FL 32206 NANCY P MENDENHALL TRUSTEE/MEDICAL DIRECTOR 40.00 X X 660786 0 23130 COLLEEN KOCH CHAIRMAN/PRESIDENT 0.30 X X 0 0 0 PAUL OKUNIEFF MD SECRETARY/TREASURER 0.30 X X 0 0 0 JONATHAN D LICHT MD TRUSTEE 0.30 X 0 0 0 RUSSELL ARMISTEAD TRUSTEE 0.30 X 0 0 0 CHARLES LANE TRUSTEE 0.30 X 0 0 0 DANIEL M EDELMAN TRUSTEE 0.30 X 0 0 0 KENNETH R HAMILTON TRUSTEE 0.30 X 0 0 0 GAE WALTERS PHD TRUSTEE 0.30 X 0 0 0 GARY DILTS TRUSTEE 0.30 X 0 0 0 STUART KLEIN EXECUTIVE DIRECTOR 40.00 X 417273 0 15749 WALTER MOORE CHIEF FINANCIAL OFFICER 40.00 X 122522 0 4261 KEVIN KIRBY DIRECTOR OF CLINICAL DOSIMETRY 40.00 X 190517 0 5768 TREVOR FLEMING DIRECTOR OF TECHNICAL SERVICES 40.00 X 181692 0 5359 EMMA V VIVIERS TREATMENT PLANNING PHYSICIST 40.00 X 183258 0 3607 NATALIYA GETMAN LEAD CERTIFIED MEDICAL DOSIMETRIST 40.00 X 144737 0 3508 WILLIAM J GLIDDEN LEAD CERTIFIED MEDICAL DOSIMETRIST 40.00 X 139109 0 3318 HEATHER K OAKLEY DIRECTOR OF SOCIAL SERVICES 40.00 X 137274 0 3931 BRIDGETTE D CARTER LEAD PEDIATRIC CERTIFIED MEDICAL DOSIMETRIST 40.00 X 131331 0 3515 TOMMIE L ALLEN CHIEF FINANCIAL OFFICER (END. 06-23) 40.00 X 160505 0 4739 2469004 0 76885 27 1 1 1 UF DEPARTMENT OF RADIATION ONCOLOGY PO BOX 100385 GAINESVILLE FL 32610 STAFFING PROVIDER 8901945 IBA PROTON THERAPY INC 151 HEARTLAND BLVD EDGEWOOD NY 11717 EQUIPMENT MAINTENANCE 6175568 JACKSONVILLE ELECTRIC AUTHORITY 7720 RAMONA BLVD W JACKSONVILLE FL 32221 UTILITIES 1695238 RC BILLING PO BOX 659831-MSC 224 SAN ANTONIO TX 78265 BILLING SERVICES 1034335 SHEPHERD 1301 RIVERPLACE BLVD SUITE 1100 JACKSONVILLE FL 32207 ADVERTISING SERVICES 992938 26 1862803 1862803 PATIENT CARE REVENUE 621500 41305882 41305882 SHARED SERVICE REVENUE 621500 1017379 1017379 42323261 777404 777404 8633696 8925493 -291797 -291797 -291797 OPERATION & MAINTENANCE REIMBURSE 621500 828269 828269 OTHER INCOME 621500 55292 55292 883561 45555232 43206822 0 485607 X 8672 8672 1621780 1282496 339284 8837470 8625463 212007 234550 222187 12363 1491525 1412909 78616 826157 782612 43545 243741 243741 51225 51225 11069844 10208812 861032 1091339 982205 109134 337259 201323 135936 284258 284258 10010853 9910745 100108 33728 33728 24117 24117 2258670 2148506 110164 4808657 4805363 3294 517835 512657 5178 SUPPLIES 1305930 1286324 19606 PATIENT PROGRAMS 44296 44296 RADIATION SAFETY 15021 9576 5445 DEBT FINANCING EXPENSE 7323 7323 4005 4005 45128255 42756526 2371729 0 7618883 8387958 10408226 11784156 4861764 4219596 1610434 1611935 114468270 55930252 62147375 58538018 1815552 1816063 23771188 24091564 26085675 26939281 138319097 137388571 2462090 3291236 52027041 49133013 324457 0 54813588 52424249 X 81884400 83829928 1621109 1134394 83505509 84964322 138319097 137388571 X 426977 84500 947336 X X 0 1 X 1 0 X 492975 1216982 3093472 2103823 1862803 8770055 46315688 42091302 36585578 41702517 42323261 209018346 150452 16650 20000 187102 46959115 43324934 39699050 43806340 44186064 217975503 0 566111 566111 566111 566111 217409392 970589 645520 425518 210476 777404 3029507 970589 645520 425518 210476 777404 3029507 966816 935332 902253 851777 883561 4539739 48896520 44905786 41026821 44868593 45847029 225544749 0.96390 0.96850 0.01340 0.01170 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: O M UNIVERSITY OF FLORIDA - 2018 AMOUNT: $ 845,174. 2019 AMOUNT: $ 845,174. 2020 AMOUNT: $ 828,270. 2021 AMOUNT: $ 828,270. 2022 AMOUNT: $ 828,269. OTHER INCOME - 2018 AMOUNT: $ 121,642. 2019 AMOUNT: $ 90,158. 2020 AMOUNT: $ 73,983. 2021 AMOUNT: $ 23,507. 2022 AMOUNT: $ 55,292. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1006957 13285 1020242 1001757 5200 1006957 800082 201675 1001757 624982 175100 800082 614982 10000 624982 1.00000 1 0 2567433 1452915 1114518 111889297 54477337 57411960 11540 11540 58538018 FIXED INCOME MUTUAL FUND 15504071 F U.S. TREASURY BILLS 8587493 F 24091564 DEPOSITS 111657 INTEREST IN LEASEHOLD 21665918 OTHER RECEIVABLES 4481150 FAIR VALUE OF INTEREST RATE SWAP AGREEMENTS 680556 26939281 X 46499290 84500 859558 944058 45555232 0 45555232 45040477 0 45040477 87778 87778 45128255 PART V, LINE 4: ENDOWMENT FUNDS ARE ESTABLISHED AS A MEANS TO PROVIDE FUTURE CASH FLOWS FOR OPERATIONS AND OTHER PURPOSES DESIGNATED BY THE INSTITUTE'S DONORS. PART X, LINE 2: THE INSTITUTE IS RECOGNIZED AS AN ORGANIZATION EXEMPT FROM FEDERAL INCOME TAX UNDER 501(A) AS ENTITIES DESCRIBED IN SECTION 501(C)(3) OF THE U.S. INTERNAL REVENUE CODE, EXCEPT FOR TAXES ON INCOME FROM ACTIVITIES UNRELATED TO ITS EXEMPT PURPOSES. THE INSTITUTE DOES NOT HAVE ANY MATERIAL, UNRECOGNIZED TAX POSITIONS THAT SHOULD BE RECOGNIZED IN THE FINANCIAL STATEMENTS FOR THE YEARS ENDED JUNE 30, 2023 OR 2022. PART XI, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSE -80,455. CHANGE IN FAIR VALUE OF INTEREST RATE SWAP 947,336. DEBT REFINANCING EXPENSE -7,323. PART XII, LINE 4B - OTHER ADJUSTMENTS: FUNDRAISING EXPENSE 80,455. DEBT REFINANCING EXPENSE 7,323. PART V, LINE 3A(I) THE FILING ORGANIZATION'S ENDOWMENT FUNDS ARE HELD AND ADMINISTERED BY THE UNIVERSITY OF FLORIDA FOUNDATION ("THE FOUNDATION"). THE FOUNDATION IS AN UNRELATED NOT-FOR-PROFIT ENTITY WHOSE PRIMARY PURPOSE IS TO RAISE FUNDS TO SUPPORT THE UNIVERSITY AND OTHER CHARITABLE ORGANIZATIONS, INCLUDING THE INSTITUTE. THE INSTITUTE HAS RECOGNIZED ITS INTEREST IN CONTRIBUTIONS RECEIVED AND HELD BY THE FOUNDATION THAT HAVE BEEN DESIGNATED BY THE DONOR FOR THE BENEFIT OF THE INSTITUTE. 0 0 0 0 0 0 0 0 0 NANCY P MENDENHALL TRUSTEE/MEDICAL DIRECTOR 660786 0 0 0 0 0 0 0 23130 0 683916 0 0 0 STUART KLEIN EXECUTIVE DIRECTOR 417273 0 0 0 0 0 0 0 15749 0 433022 0 0 0 KEVIN KIRBY DIRECTOR OF CLINICAL DOSIMETRY 190517 0 0 0 0 0 0 0 5768 0 196285 0 0 0 TREVOR FLEMING DIRECTOR OF TECHNICAL SERVICES 181692 0 0 0 0 0 0 0 5359 0 187051 0 0 0 EMMA V VIVIERS TREATMENT PLANNING PHYSICIST 183258 0 0 0 0 0 0 0 3607 0 186865 0 0 0 TOMMIE L ALLEN CHIEF FINANCIAL OFFICER (END. 06-23) 160505 0 0 0 0 0 0 0 4739 0 165244 0 0 0 SCHEDULE J, PART I, LINE 3 THE FILING ORGANIZATION'S EXECUTIVE DIRECTOR, STUART KLEIN, AND THE MEDICAL DIRECTOR, DR. NANCY MENDENHALL, WERE COMPENSATED BY THE UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE, AN UNRELATED ENTITY, FOR SERVICES PROVIDED TO THE FILING ORGANIZATION. THE EXECUTIVE DIRECTOR'S COMPENSATION WAS DETERMINED ACCORDING TO THE UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE'S POLICIES AND PROCEDURES. FORM 990, PART VII, LINE 5 THE FILING ORGANIZATION'S EXECUTIVE DIRECTOR, STUART KLEIN, AND THE MEDICAL DIRECTOR, DR. NANCY MENDENHALL, WERE COMPENSATED BY THE UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE, AN UNRELATED ENTITY, FOR SERVICES PROVIDED TO THE FILING ORGANIZATION. COMPENSATION FOR THESE INDIVIDUALS HAS BEEN REPORTED IN PART II, ROW (I) ACCORDING TO IRS GUIDELINES. A JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION 596000344 2012-08-01 25580000 SEE SUPPLEMENTAL INFORMATION - PART V 1 0 0 B JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION 596000344 46936FAN8 2017-08-18 27250000 SEE SUPPLEMENTAL INFORMATION - PART V 0 0 0 C JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION 596000344 46936FAN8 2017-08-18 27250000 SEE SUPPLEMENTAL INFORMATION - PART V 0 0 0 A 16749000 25580000 15308 25564692 2012 1 0 1 1 B 4423912 27240000 1800408 283371 6039492 19116729 2017 1 0 1 1 C 8905000 27225000 283371 7824900 19116729 2017 1 0 1 1 A 0 0 0 0 0 0 0 B 0 0 0 0 0 0 0 C 0 0 0 0 0 0 0 A 0 0 0 1 1 1 JP MORGAN CHASE BANK NA 20.000000000000 0 0 0 0 1 B 0 1 0 0 1 1 TRUIST BANK 10.000000000000 0 0 0 0 1 C 0 1 0 0 1 1 TRUIST BANK 14.000000000000 0 0 0 0 1 A 1 B 1 C 1 DATE REBATE COMPUTATION PERFORMED ISSUER NAME: JACKSONVILLE ECONOMIC DEVELOPMENT COMMISSION DATE THE REBATE COMPUTATION WAS PERFORMED: 06/30/2017 SCHEDULE K PART I COLUMN F LINES A & B THE SERIES 2007B BONDS AND SERIES 2017 BONDS WERE ISSUED PURSUANT TO THE INDENTURE, WHICH PROVIDES, AMONG OTHER THINGS, THAT THE INSTITUTE MAINTAIN CERTAIN MINIMUM FINANCIAL RATIOS. THE SERIES 2007B BONDS AND SERIES 2017 BONDS ARE COLLATERALIZED BY EQUIPMENT, MACHINERY, AND OTHER PERSONAL PROPERTY, INCLUDING THE INSTITUTE'S GROSS REVENUES, AS DEFINED IN THE INDENTURE. ON AUGUST 1, 2012, AS PART OF A MODIFICATION OF THE SERIES 2007B BONDS, THE INSTITUTE REPAID $12,110,000 OF THE SERIES 2007B BONDS TO REDUCE THE REMAINING UNPAID PRINCIPAL BALANCE TO $32,580,000. THE SERIES 2007B BONDS WERE THEN REPLACED WITH (A) $25,580,000 OF SERIES 2007B-1 BONDS AND (B) $7,000,000 OF SERIES 2007B-2 BONDS. SCHEDULE K PART I COLUMN F LINES C & D ON AUGUST 18, 2017, THE INSTITUTE ISSUED SERIES 2017A BONDS AND SERIES 2017B BONDS PURSUANT TO AN INDENTURE (COLLECTIVELY, THE "SERIES 2017 BONDS") AS PART OF A REFINANCING OF THE 2007A BONDS. THE PROCEEDS OF THE SERIES 2017 BONDS, ALONG WITH THE REMAINING AVAILABLE BALANCE OF THE SERIES 2007A BOND FUND AND DEBT SERVICE RESERVE FUND, WERE USED TO (A) REFUND THE REMAINING AMOUNTS DUE ON AND EXTINGUISH THE SERIES 2007A BONDS ON SEPTEMBER 1, 2017, (B) PAY THE COSTS OF ISSUANCE, AND (C) PROVIDE FUNDING FOR THE INSTITUTE'S PLANNED EXPANSION. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 WILL FIRST BE REVIEWED AND APPROVED BY THE CHIEF FINANCIAL OFFICER. SUBSEQUENT TO THE CFO'S APPROVAL, FORM 990 WILL BE PROVIDED TO THE BOARD OF DIRECTORS FOR REVIEW AND APPROVAL PRIOR TO FILING IT WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION'S GOVERNING BODY MONITORS AND ENFORCES COMPLIANCE WITH THE CONFLICT OF INTEREST POLICY ANNUALLY. THE GOVERNING BODY REVIEWS ACTUAL CONFLICTS, IF ANY, THAT ARE IDENTIFIED BY THE ANNUAL DISCLOSURE PROCESS AND PROHIBITS OFFICERS AND DIRECTORS FROM VOTING ON MATTERS WHERE ACTUAL CONFLICTS OF INTEREST EXIST. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE DIRECTOR AND MEDICAL DIRECTOR'S COMPENSATION IS CONTROLLED AND APPROVED BY THE UNIVERSITY OF FLORIDA. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC AND ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G CONTRACTED HEALTHCARE SERVICES: PROGRAM SERVICE EXPENSES 7,928,336. MANAGEMENT AND GENERAL EXPENSES 441,142. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 8,369,478. BILLING AND COLLECTION SERVICES: PROGRAM SERVICE EXPENSES 1,398,230. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,398,230. OTHER PURCHASED SERVICES: PROGRAM SERVICE EXPENSES 427,837. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 427,837. CONSULTING SERVICES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 81,038. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 81,038. UF FOUNDATION MANAGEMENT FEES: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 80,455. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 80,455. TEMP SERVICES: PROGRAM SERVICE EXPENSES 454,409. MANAGEMENT AND GENERAL EXPENSES 258,397. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 712,806. FORM 990, PART XI, LINE 9: CHANGE IN FAIR VALUE OF INTEREST RATE SWAP 947,336. FORM 990, PART XII, LINE 2C OVERSIGHT OF AUDIT AND SELECTION OF INDEPENDENT ACCOUNTANT: THE GOVERNING BODY IS RESPONSIBLE FOR THE SELECTION, MONITORING AND EVALUATION OF AN INDEPENDENT AUDIT FIRM AND OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS. THERE WAS NO CHANGE IN THIS PROCESS FROM THE PRIOR YEAR. GENERAL DISCLOSURE CHARITY CARE: THE INSTITUTE PROVIDES CARE TO PATIENTS WHO MEET CERTAIN CRITERIA UNDER ITS CHARITY CARE POLICY WITHOUT CHARGE OR AT AMOUNTS LESS THAN ITS ESTABLISHED RATES. BECAUSE THE INSTITUTE DOES NOT PURSUE COLLECTION OF AMOUNTS DETERMINED TO QUALIFY AS CHARITY CARE, THEY ARE NOT REPORTED AS NET PATIENT SERVICE REVENUE. DURING THE YEARS ENDED JUNE 30, 2023 AND 2022, THE INSTITUTE RECOGNIZED AN EXPLICIT PRICE CONCESSION FROM CHARITY CARE OF APPROXIMATELY $340,000 AND $27,000, RESPECTIVELY. THE TOTAL DIRECT AND INDIRECT COSTS OF THESE SERVICES WERE APPROXIMATELY $441,000 AND $35,000 FOR THE YEARS ENDED JUNE 30, 2023 AND 2022, RESPECTIVELY. THE INSTITUTE PARTICIPATES IN SEVERAL LOCAL/NATIONAL CANCER AND CHILDREN WELLNESS FUND RAISING EVENTS AS SPONSORS AND PARTICIPANTS. THE INSTITUTE ALSO PROVIDES SEVERAL EDUCATIONAL SEMINARS TO COMMUNITIES WITHIN THE SOUTHEAST RELATED TO CANCER PREVENTION AND TREATMENT OPTIONS. IN ADDITION, WEEKLY EDUCATIONAL OPPORTUNITIES ARE AVAILABLE TO PATIENTS, CAREGIVERS AND INVITED GUESTS RELATED TO CARE DURING AND AFTER TREATMENT.